Friday, December 11, 2015

The first pharmaceutical use 3D printing technology

Spritam name pharmaceutical drug is in the form of capsules used to treat seizures epilepsy patients was first U.s. license for using 3D printing technology.
The first pharmaceutical use 3D printing technology
Spritam name pharmaceutical drug is in the form of capsules used to treat seizures epilepsy patients was first U.s. license for using 3D printing technology.

Aprecia pharmaceuticals company based in the State of Ohio said in the airline's system allows the production of the tablet with up to 1000 mg/capsules.

Through the 3D printing process, the tablet was created as a porous, can melt easily in a small amount of fluid, causing the use of medication more convenient for children as well as the dysphagia.

3D printing technology was invented in the 80s of the last century, the use of a laser to create the physical metal or plastic according to digital design. The point of this technology is creating templates and customize the device quickly with low cost.

Does the medical industry are pushing the application of advanced technology to manufacture the parts of complex implant for patients with rare disease or meet special injury.

Speaking to the press, FDA spokesman Sandy Walsh said Spritam is the first drug produced by 3D printing technology is the Agency on through. Spritam, also called Levetiracetam, were circulating on the market for many years in many different formats.

Previously, the FDA has also "green light" for a number of other medical products manufactured by 3D printing as the artificial parts replaced in the human body.

Under the plan, Aprecia will begin distributing the drugs on the in the 1st quarter of next year. The company also said in the future will continue to use this advanced technology to develop many other drugs.

In recent years, the 3D printing technology is increasingly developing strong and companies were able to use them to create complex objects from metals, such as titanium or aluminium.

No comments:

Post a Comment